#DrugCompounding
FDA Matters recently published an important column on the need for FDA to maintain firm boundaries around all drug compounding, not just GLP-1’s. Otherwise, FDA risks creating two systems, one regulated, one not.

www.fdamatters.com/fdamatters/a...

#FDAMatters #DrugCompounding #GLP-1
A Dangerous Idea: Two Drug Manufacturing Pathways–One Regulated, One Not — FDA Matters
Today, May 22, 2025, is the last day that mass compounded GLP-1 obesity medicines can be sold. Yet, some companies intend to continue selling compounded GLP-1 drugs to a large number of their customer...
www.fdamatters.com
June 6, 2025 at 4:54 PM
#OnlineFirst w/#PMT #JPharmTechnol - Cho et al @UnionUniversity +Jackson-Madison Hospital show success of advanced robotic chemotherapy drug compounding system APOTECAchemo in a community cancer center
journals.sagepub.com/doi/abs/10.1...
#pharmacists #drugcompounding #Cancer
Implementation and Evaluation of APOTECAchemo in a Community Cancer Center: A Comparative Study of Robotic Versus Manual Antineoplastic Preparation - Han Na Cho, Lyn Wells, Zachery Halford, 2024
Background: The ever-increasing complexity and demand for antineoplastic therapy necessitates innovative solutions to improve the accuracy and safety of drug pr...
journals.sagepub.com
October 31, 2024 at 3:16 PM